S100A8

S100A8 분자 정보

영어 이름S100 calcium binding protein A9시판 약물 수0
임상 약물 수2표적 별명Protein S100-A9,CAGB,MRP-14,S100 calcium-binding protein A9,p14,S100A9,S100 Calcium Binding Protein A9,Migration Inhibitory Factor-Related Protein 14,Leukocyte L1 Complex Heavy Chain,Calprotectin L1H Subunit,MRP14,CFAG,S100 Calcium-Binding Protein A9 (Calgranulin B),Calgranulin-B,60B8AG,MAC387,CGLB,L1AG,LIAG,MIF,NIF,Calgranulin B
최고 연구 개발 단계Phase 2 Clinical
영어 이름S100 calcium binding protein A9
표적 별명Protein S100-A9,CAGB,MRP-14,S100 calcium-binding protein A9,p14,S100A9,S100 Calcium Binding Protein A9,Migration Inhibitory Factor-Related Protein 14,Leukocyte L1 Complex Heavy Chain,Calprotectin L1H Subunit,MRP14,CFAG,S100 Calcium-Binding Protein A9 (Calgranulin B),Calgranulin-B,60B8AG,MAC387,CGLB,L1AG,LIAG,MIF,NIF,Calgranulin B
시판 약물 수0
임상 약물 수2
최고 연구 개발 단계Phase 2 Clinical

S100A8 제품 목록

  • 속성

    Protein (1)

  • 제품 라이브러리

    온라인 (1)

  • Human (1)

  • 태그

    Tag Free (1)

  • 마커

    Unconjugated (1)

제품 번호발현 시스템제품 설명단백질 구조순도특성
S18-H5112
Human
E. coli
Human S100A8 Protein, Tag Free
총 수량1
  • 1

S100A8분자 배경

S100 calcium binding protein A8 (S100-A8) is also kown as Cystic fibrosis antigen, Migration inhibitory factor-related protein 8 60B8AG, CAGA, CFAG, CGLA, CP-10, L1Ag, MA387, MIF, MRP8, NIF and P8, is a member of the S100 family of proteins containing 2 EF-hand calcium-binding motifs. S100 proteins are localized in the cytoplasm and/or nucleus of a wide range of cells, and involved in the regulation of a number of cellular processes such as cell cycle progression and differentiation. S100 genes include at least 13 members which are located as a cluster on chromosome 1q21. Most S100 proteins are disulfide-linked homodimer, and is normally present in cells derived from the neural crest, chondrocytes, macrophages, dendritic cells, etc. S100A8 plays a role in various functions of myeloid cells by forming a heterocomplex with S100A9. S100A8 and S100A9 are known to be overexpressed in certain species of carcinomas. S100A8 may function in the inhibition of casein kinase and as a cytokine. Altered expression of this protein is associated with the disease cystic fibrosis. S100A8 plays an important role in differentiation of thyroid carcinoma possibly by forming a complex with S100A9. S100A8 and S100A9 may also play a key role in inflammation-associated cancer.

S100A8분자 별명

S100A8,60B8AG,CAGA,CFAG,CGLA,CP-10,MRP8,NIF,P8

임상 약물 정보

영어 이름연구 코드연구 개발 단계회사적응증임상 시험
DukiprubartSGC-001; ZYB-0069Phase 2 ClinicalBeijing Sungen Biomedical Technology Co LtdAnterior Wall Myocardial Infarction; Myocardial Infarction; ST Elevation Myocardial Infarction
상세
TasquinimodABR-215050; TASQ; ABR-5050Phase 2 ClinicalActive Biotech AbCarcinoma, Renal Cell; Hormone-Resistant Prostate Neoplasms; Multiple Myeloma; Ovarian Neoplasms; Polycythemia Vera; Primary Myelofibrosis; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Stomach Neoplasms; Thrombocythemia, Essential
상세
  • 분자 정보
  • 제품 목록
  • 임상 약물 정보
문의하기

전화
글로벌: +1 800-810-0816 (무료)
아시아태평양: +86 400-682-2521

주소 서울특별시 송파구 법원로11길 11, 제3층 제비-314,315호